Literature DB >> 23733466

Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir.

J Trevillyan1, P Angus, E Shelton, J Whitlam, F Ierino, J Pavlovic, D Gregory, K Urbancic, J Torresi, A Testro, M L Grayson.   

Abstract

In a prospective study of solid-organ transplant recipients (n = 22; 15 hepatic and 7 renal) receiving valganciclovir for cytomegalovirus (CMV) prophylaxis, electronic estimation of glomerular filtration rate (eGFR) underestimated the true GFR (24-h urine creatinine clearance) by >20% in 14/22 (63.6%). Its use was associated with inappropriate underdosing of valganciclovir, while the Cockroft-Gault equation was accurate in 21/22 patients (95.4%). Subtherapeutic ganciclovir levels (≤ 0.6 mg/liter) were common, occurring in 10/22 patients (45.4%); 7 had severely deficient levels (<0.3 mg/liter).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23733466      PMCID: PMC3719737          DOI: 10.1128/AAC.00375-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients.

Authors:  J A Fishman; M T Doran; S A Volpicelli; A B Cosimi; J G Flood; R H Rubin
Journal:  Transplantation       Date:  2000-02-15       Impact factor: 4.939

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis.

Authors:  C Piketty; C Bardin; J Gilquin; A Gairard; M D Kazatchkine; F Chast
Journal:  Clin Microbiol Infect       Date:  2000-03       Impact factor: 8.067

4.  Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.

Authors:  A Erice; M C Jordan; B A Chace; C Fletcher; B J Chinnock; H H Balfour
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

Review 6.  Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Authors:  Elisabeth M Hodson; Maleeka Ladhani; Angela C Webster; Giovanni F M Strippoli; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  Ganciclovir-resistant cytomegalovirus in organ transplant recipients.

Authors:  Ajit P Limaye
Journal:  Clin Infect Dis       Date:  2002-09-10       Impact factor: 9.079

8.  Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients.

Authors:  C E Chamberlain; S R Penzak; R M Alfaro; R Wesley; C E Daniels; D Hale; A D Kirk; R B Mannon
Journal:  Am J Transplant       Date:  2008-04-29       Impact factor: 8.086

Review 9.  A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.

Authors:  Martin Tidman; Per Sjöström; Ian Jones
Journal:  Nephrol Dial Transplant       Date:  2007-10-02       Impact factor: 5.992

10.  Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

Authors:  Jason L Sanchez; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more
  3 in total

1.  Underdosing of prophylactic valganciclovir due to inaccurate estimation of glomerular filtration rate leading to severe cytomegalovirus disease in a kidney transplant recipient.

Authors:  E L Penne; S A Nurmohamed
Journal:  Antimicrob Agents Chemother       Date:  2014       Impact factor: 5.191

2.  Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis.

Authors:  Diana D Wong; Wendy J van Zuylen; Talia Novos; Sophie Stocker; Stephanie E Reuter; Jane Au; Charles S P Foster; Richard O Day; Andrea R Horvath; Zoltan Endre; William D Rawlinson
Journal:  Microbiol Spectr       Date:  2022-06-06

3.  Use of leflunomide in renal transplant recipients with ganciclovir-resistant/refractory cytomegalovirus infection: a case series from the University of Chicago.

Authors:  W James Chon; Pradeep V Kadambi; Chang Xu; Yolanda T Becker; Piotr Witkowski; Kenneth Pursell; Brenna Kane; Michelle A Josephson
Journal:  Case Rep Nephrol Dial       Date:  2015-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.